Want to join the conversation?
During 1Q16, $ADM's asset impairment, exit, and restructuring charges rose $13MM due to software impairment and restructuring charges. Other income fell $29MM to an expense of $19MM mainly as a result of foreign exchange losses compared to foreign exchange gains in the prior period.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.